GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

BACKGROUND: First Spanish trial of Ewing sarcoma (ES) including adults and children with the aim to test the efficacy of Gemcitabine and Docetaxel (G/D) in newly diagnosed high-risk (HR) patients. METHODS: This was a prospective, multicentric, non-randomised, open study for patients ⩽40 years with n...

全面介紹

Na minha lista:
書目詳細資料
發表在:Br J Cancer
Main Authors: Mora, J, Castañeda, A, Perez-Jaume, S, Lopez-Pousa, A, Maradiegue, E, Valverde, C, Martin-Broto, J, Garcia del Muro, X, Cruz, O, Cruz, J, Martinez-Trufero, J, Maurel, J, Vaz, M A, de Alava, E, de Torres, C
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2017
主題:
Clinical Study
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589997/
https://ncbi.nlm.nih.gov/pubmed/28787430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.252
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍